Indeed, significant inhibition of proliferation as compared to controls was already observed with doses as low as 0.1 μM RGS in PLC cells, and 0.5 μM RGS was sufficient to completely block cell prolifaration in both HCC cell lines (Figure 2B). Here, HSPG2 is linked to hepatocellular carcinoma.